FEB 07, 2020 6:07 AM PST

New diagnostic technology uses levitating proteins

WRITTEN BY: Tara Fernandez

Intrinsic biophysical properties of proteins hold valuable clues about how they function and their role in disease. Take, for example, one of the most commonly-used biological samples used to provide diagnostic answers: blood. A plethora of different proteins exist in blood plasma, from carrier proteins that transport hormones and vitamins, to globulins which serve as key components of the immune system.

Examining the 3-dimensional structures and physical properties of these blood proteins at high resolution would reveal a wealth of information, enabling the creation of specific proteomic profiles for different diseases. Unfortunately, however, this has remained outside the realm of possibility for researchers and clinicians due to the lack of appropriate analytical tools.

Morteza Mahmoudi, a professor at the Department of Radiology Nanoscience and Nano Biomedical Engineering at Michigan State University, has developed a new nanotechnology platform that can unveil previously hidden protein features with unprecedented resolution.

Here, magnetic nanoparticles are added to plasma samples, which naturally associate and bind to each other. This cocktail is then placed within a magnetic field, where the magnetic force causes proteins to “levitate”, separating them into bands based on their relative densities.

These bands form distinctive patterns that could provide vital indications on the health status of an individual. 

According to Mahmoudi, the next step in their research is to validate their platform for defining signature levitating protein profiles for cancer and multiple sclerosis (MS). At present, positively diagnosing MS involves using subjective measures, including monitoring the patient’s symptoms, behavior or response to initial treatments.

“There is no biomarker or MRI test to diagnose the different subtypes at the early stages. Correctly diagnosing the type of MS is critical, since it dictates which type of treatment is appropriate. We hope this MagLev method will give clinicians a technique to define the subtypes,” said Mahmoudi.

In addition, magnetic nanoparticles can also be used in other applications, including cancer therapies, genetic engineering and diagnosing bacterial infections.

 



Sources: Medgadget, Analytical Chemistry.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 22, 2020
Clinical & Molecular DX
Unmasking the Secrets of the Substantia Nigra to Diagnose Parkinson's
JUL 22, 2020
Unmasking the Secrets of the Substantia Nigra to Diagnose Parkinson's
Parkinson’s disease is a devastating condition whereby neurons in a specific region of the brain that controls mov ...
AUG 04, 2020
Clinical & Molecular DX
Alzheimer's Blood Test Serves as a Crystal Ball
AUG 04, 2020
Alzheimer's Blood Test Serves as a Crystal Ball
According to a recent study, the answers could lie in a simple blood test.
AUG 13, 2020
Clinical & Molecular DX
A Call for Bigger, Better Studies on AI Breast Cancer Diagnostics
AUG 13, 2020
A Call for Bigger, Better Studies on AI Breast Cancer Diagnostics
A staggering 1 in 8 women in the U.S. will develop an aggressive form of breast cancer in their lifetime, making it the ...
AUG 15, 2020
Genetics & Genomics
How Dermatitis is Linked to Increased Risk of Food Allergies
AUG 15, 2020
How Dermatitis is Linked to Increased Risk of Food Allergies
Small changes in the genome can sometimes have a huge impact, and researchers have found two that increase the risk of e ...
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
Loading Comments...